Related Experiment Video

Updated: Jun 8, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.8K

[HBsAg trajectory and key watersheds towards functional cure of hepatitis B]

X E Liang1, Z H Liu1, Y Y Li1

  • 1Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou510515, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|November 7, 2024
PubMed

Insights

Achieving a functional cure for chronic hepatitis B virus (HBV) infection is challenging. Novel antiviral drugs and predictive models for hepatitis B surface antigen (HBsAg) are advancing treatment strategies.

Area of Science:

  • Hepatology
  • Virology
  • Drug Discovery

Context:

  • Chronic hepatitis B virus (HBV) infection is a significant global health issue.
  • Current treatments like nucleos(t)ide analogues (NAs) and pegylated interferon alfa (PEG-IFN-α) have limitations in achieving a functional cure.
  • There is an unmet clinical need for effective hepatitis B functional cure strategies.

Purpose:

  • To explore novel antiviral drug mechanisms for HBV functional cure.
  • To develop trajectory mapping and prediction models for HBV functional cure.
  • To optimize personalized management of hepatitis B patients using HBsAg levels.

Summary:

  • Nucleos(t)ide analogues (NAs) suppress HBV DNA but do not achieve functional cure.
  • Novel antiviral drugs, particularly small nucleic acid drugs, show promise for hepatitis B functional cure.
  • Functional cure trajectory mapping and prediction models using longitudinal HBsAg data can guide treatment and clinical trial screening.

Impact:

  • Advances in small nucleic acid drugs offer new hope for hepatitis B functional cure.
  • Predictive models for HBsAg levels can personalize treatment and improve clinical trial design.
  • Optimized patient management strategies may lead to better outcomes for chronic hepatitis B.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.2K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
3